CLM
IRWD icon

ClearBridge LLC (Maryland)’s Ironwood Pharmaceuticals IRWD Stock Holding History

ClearBridge LLC (Maryland)’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-932,919
Closed -$12.1M – 188
2018
Q1 		$12.1M Sell
932,919
-17,098
-2% -$213K 0.27% 108
2017
Q4 		$11.9M Buy
950,017
+90,255
+10% +$1.18M 0.25% 113
2017
Q3 		$11.4M Buy
859,762
+72,308
+9% +$995K 0.25% 108
2017
Q2 		$12.5M Buy
787,454
+76,027
+11% +$1.1M 0.26% 95
2017
Q1 		$10.2M Sell
711,427
-29,265
-4% -$400K 0.22% 102
2016
Q4 		$9.48M Buy
740,692
+274,513
+59% +$3.47M 0.21% 97
2016
Q3 		$6.2M Hold
466,179
– – 0.12% 115
2016
Q2 		$5.11M Buy
466,179
+25,492
+6% +$249K 0.1% 117
2016
Q1 		$4.04M Buy
+440,687
New +$3.63M 0.08% 121

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge LLC (Maryland)'s IRWD Position: Q2 2018 in Review

ClearBridge LLC (Maryland) sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2018, closing a stake of 932,919 shares — an estimated $12.1M sold.

ClearBridge LLC (Maryland) first reported a position in IRWD in Q1 2016 and held it in 9 quarters. The position peaked at $12.5M in Q2 2017. 148 funds tracked by Wall St. Rank hold IRWD as of Q2 2018.

  • ClearBridge LLC (Maryland) reported no remaining Ironwood Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • ClearBridge LLC (Maryland) sold 932,919 Ironwood Pharmaceuticals shares in Q2 2018, an estimated $12.1M.
  • ClearBridge LLC (Maryland) first reported a position in Ironwood Pharmaceuticals in Q1 2016 and held it in 9 quarters.
  • ClearBridge LLC (Maryland)'s Ironwood Pharmaceuticals position peaked at $12.5M in Q2 2017.
  • 148 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2018.

Based on ClearBridge LLC (Maryland)'s 13F filing for Q2 2018, filed 14 Aug 2018.